2019 | Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-US Free Trade Agreement in Korea | 배승진; 손경복 | Article |
2021 | How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements | 배승진; 손경복 | Article |
2019 | How Much Time Before Attempting Compulsory Licensing of Pharmaceuticals? A Non-parametric Event History Model With P-splines | 손경복 | Article |
2019 | Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: A cross-sectional analysis | 손경복 | Article |
2020 | Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea | 배승진; 이동환; 손경복 | Article |
2020 | Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate | 배승진; 손경복 | Article |
2018 | Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States | 손경복 | Article |
2019 | Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study | 배승진; 손경복 | Article |
2019 | Public perceptions of the roles and functions of community pharmacies in the era of expanding scopes of pharmaceutical practice: A questionnaire survey in South Korea | 손경복 | Article |
2020 | The Burden of Cervical Cancer in Korea: A Population-Based Study | 배승진; 이동환; 손경복 | Article |
2018 | Understanding the adoption of new drugs decided by several stakeholders in the South Korean market: A nonparametric event history analysis | 손경복 | Article |
2019 | Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients | 배승진; 손경복 | Article |